GSK_WRN2 is a potent, selective covalent inhibitor of the WRN helicase, which targets replication stress caused by the amplification of DNA (TA)n dinucleotide repeats. It can be utilized in research focusing on microsatellite instability (MSI) cancers.
Target:
DNA/RNA Synthesis
* VAT and and shipping costs not included. Errors and price changes excepted
